2026-01-23 - Analysis Report
**Company Overview**
Invesco is a global investment management company that offers a range of investment products and services to investors.

**Return Rate Comparison**
IVZ: 31.68%
VOO: 92.53%
Divergence: -60.70 (relative divergence: 34.40%)
The comparison stock (VOO) has a significantly higher cumulative return than IVZ.

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -43.0% | 39.3% | -48.0% | 1.4 | 7.5B |
| 2017-2019  | -26.0% | 39.3% | -43.0% | 1.2 | 8.0B |
| 2018-2020  | -26.0% | 37.6% | -47.0% | 1.5 | 7.8B |
| 2019-2021  | 29.0% | 32.4% | -14.0% | 1.6 | 10.3B |
| 2020-2022  | 20.0% | 32.4% | 22.0% | 1.6 | 8.0B |
| 2021-2023  | -3.0% | 31.1% | -4.0% | 1.5 | 8.0B |
| 2022-2024  | -4.0% | 26.6% | -23.0% | 1.4 | 7.8B |
| 2023-2025  | 32.0% | 34.3% | -30.0% | 1.5 | 11.7B |

IVZ has experienced a range of performances across different years, with negative CAGR in 2016-2018 and positive CAGR in 2019-2021.

**Recent Stock Price Fluctuations**
* Close: $29.24
* Last-market: $29.24 (0.24% increase)
* 5-day SMA: $29.03
* 20-day SMA: $27.96
* 60-day SMA: $25.70
The stock price has shown a small increase in the last market, but its short-term moving averages are still below the current price.

**RSI, PPO Analysis**
* RSI: 68.18
* PPO: -0.02
* Risk Level: High (MRI 0.90)
* Recent (20 days) relative divergence change: 4.40 (+) (improving)
* 7-day Rank change: 0 (0) (flat)
* 7-day Dynamic Expected Return change: 0.00 (0) (flat)
The stock's RSI is above 50, indicating that it is considered overbought. The PPO is also negative, indicating a decline in price momentum.

**Recent Headlines**
[2026-01-22] Exploring Analyst Estimates for Invesco (IVZ) Q4 Earnings, Beyond Revenue and EPS - Yahoo Finance
[2026-01-21] Invesco (IVZ) Stock Trades Up, Here Is Why - The Globe and Mail
[2026-01-22] RBC Capital Upgrades Invesco (IVZ) - Nasdaq
[2026-01-21] IVZ Stock Upgraded to "Outperform" with Raised Price Target by R - GuruFocus
[2026-01-21] Invesco ETF Comparisons Put Spotlight On RSP QQQ And Valuation - simplywall.st
[2026-01-15] Why Invesco (IVZ) Stock Is Trading Up Today - Finviz

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.33 (~Buy)
- Opinions: 11
- Target Price (avg/high/low): 30.30 / 35.00 / 24.00

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|-----|-----|---------|
| 2025-11-04 | 0.67 | 1.64 B$ |
| 2025-08-01 | -0.03 | 1.52 B$ |
| 2025-04-28 | 0.38 | 1.53 B$ |
| 2024-10-29 | 0.12 | 1.52 B$ |
| 2025-11-04 | 0.12 | 1.52 B$ |

IVZ has reported a mix of positive and negative EPS and revenue in recent quarters.

**Financial Information**

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.64B | 34.17% |
| 2025-06-30 | $1.52B | 33.28% |
| 2025-03-31 | $1.53B | 36.33% |
| 2024-12-31 | $1.59B | 37.83% |
| 2024-09-30 | $1.52B | 25.76% |

IVZ has reported positive profit margins across all quarters, with some fluctuations.

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $14.01B | 2.47% |
| 2025-06-30 | $13.87B | 1.47% |
| 2025-03-31 | $14.70B | 1.57% |
| 2024-12-31 | $14.56B | 1.84% |
| 2024-09-30 | $14.75B | 0.77% |

IVZ has reported a range of equity and ROE values across quarters, indicating some fluctuations in its financial performance.

**Comprehensive Analysis**
Based on the analysis, IVZ has shown a mix of positive and negative performances across different periods. The stock's RSI is above 50, indicating that it is considered overbought, and its PPO is negative, indicating a decline in price momentum. The company's financial performance has also shown some fluctuations in recent quarters. The analyst opinions suggest a consensus "Buy" recommendation with a target price range of $24.00 to $35.00. Overall, further research and analysis are required to determine the stock's future performance.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.